Belimumab concentration measurements using a homologous anti-idiotype immunoassay

Monitoring belimumab concentrations in patients can be a valuable tool for assessing treatment response and for personalizing drug doses. Various assay formats may be used to measure concentrations of therapeutic monoclonal antibodies. A particularly useful format involves the use of anti-idiotype monoclonal antibodies, selected to be highly specific to the antibody of interest. Here, we describe the development of a specific, high-affinity anti-idiotype antibody to belimumab, and the application of this antibody in a homologous sandwich ELISA to measure belimumab concentrations. •We developed a specific, high-affinity anti-idiotype antibody to belimumab•The antibody was successfully applied in a homologous sandwich ELISA to measure belimumab concentrations•Monitoring belimumab concentrations in patients can be a valuable tool for assessing treatment response and for personalizing drug doses.